do not receive it. There are 3 sources of costs that may arise from such under-utilisation: 1. increased morbidity and … mortality associated with under-use 2. increased demand for related medical resources when the health state following an AMI is … category of costs; 1 recent study does address this issue and indicates that beta-blocker therapy can lead to a 22% relative …

. The effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality … replacement of older drugs by newer drugs. The effect of the vintage of chemotherapy treatments on age-adjusted cancer mortality … mortality rates, and may have accounted for as much as half of the decline. …

results on YPLL, eight on mortality costs and five on morbidity costs. Some studies reported results in more than one category … per death and morbidity and mortality costs. The average number of YPLL per death was approximately 15 for melanoma and 10 … published literature that skin cancer leads to significant YPLL and indirect costs associated with premature mortality and …

Heart and Lung Transplantation (ISHLT) overall survival statistics. Incremental costs and incremental cost …-effectiveness ratios were determined using various sources of data, and both costs and consequences were discounted by 3% per year …-years thereafter. Discounted costs per year of life gained were $US1050 (sensitivity analyses $US800 to $US15 400) for simvastatin plus …

mortality is equally significant and has been conservatively estimated at $US30 billion dollars annually, and could exceed $US … mortality has become an increasingly important requirement for reducing healthcare expenditures. This article will review …

lowered rates of total mortality and rehospitalisation due to heart failure. Design and Setting: The cost … was used which was based on secondary analysis of existing data, and costs were those incurred by SHI (i.e. expenses of …

switched from a weak to a strong opioid so that the expected direct healthcare costs in the UK could be estimated from the time … costs. Management of patients in the community by the primary healthcare team accounted for between 10 and 40% of the costs … drugs sold to hospitals did not impact substantially on the total expected costs. The use of other resources such as …

simulated total management costs for the 4986 patients diagnosed with stage IV NSCLC in Canada in 1992. The other applied US … exclusion of some costs for hospitalisation and/or management of toxicity. Conclusions. Although some limitations apply, the …